Package 51

This tender concerns the supply of a pharmaceutical product, specifically an ointment designated as Package 51. The ointment must contain 3% liquid extract of potentilla rhizome, 2% ichthammol (ichthyol), and 20% zinc oxide, presented in a 30g unit. A critical exclusion criterion is that the product must not contain sodium tetraborate. Furthermore, the preparation is approved for use in children. The required quantity for this supply is 800 units. This procurement falls within the pharmaceutical or healthcare sector, requiring adherence to specific formulation standards and safety regulations, particularly concerning pediatric use. Potential bidders are expected to provide a product that meets all specified compositional requirements and regulatory approvals. The tender emphasizes the need for a safe and effective topical treatment suitable for a pediatric population, highlighting the importance of precise ingredient percentages and the absence of prohibited substances. The successful bidder will be responsible for delivering the specified quantity of this specialized ointment.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and General Supplies. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.